Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

NCT00685828 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
946
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators